An observational study in Cataract, sponsored by ICARES Medicus, Inc.. Completed at 1 site in Taiwan. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-04-20.
Sponsored by ICARES Medicus, Inc. · Observational
This is an observational, single-center, non-control, open-label post-marketing study. Patients implanted with an aspicio™ Monofocal Intraocular Lens will be scheduled for a follow-up visit at least 3 months after the surgery to undergo a routine basic ophthalmological examination.
This is an observational, single-center, non-control, open-label post-marketing study. Patients implanted with an aspicio™ Monofocal Intraocular Lens will be scheduled for a single visit in the facilities of Chang Gung University Hospital at least 3 months after the surgery. Patients will undergo a routine basic ophthalmological examination.
Additionally, and retrospectively, the patients' medical records will be reviewed to obtain information on visual acuity and adverse events at postoperative visit carried out 1 month after surgery.
The data corresponding to the preoperative values of corneal curvature (flat meridian, curved meridian and axes), axial length measured by biometry, visual acuity and those corresponding to the implanted IOL will also be collected from the medical records.
1,701 studies on the registry are indexed under Cataract; 230 are open to participants now.
This study's enrollment of 30 is below the median of 81 across 484 observational studies indexed under Cataract.
Browse Cataract studies →ICARES Medicus, Inc. is the lead sponsor of 2 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Male or female adult patients who have been implanted with aspicio™ monofocal intraocular lens in at least 1 eye
Exclusion Criteria:
A bi-aspheric monofocal IOL is implanted through preloaded IOL Delivery System in the capsular bag in the posterior chamber of the eye during cataract surgery
Device: aspicio Monofocal IOL
A bi-aspheric monofocal IOL is implanted through preloaded IOL Delivery System in the capsular bag in the posterior chamber of the eye during cataract surgery
Also known as: aspicio Monofocal, Asqelio Monofocal, ASPP60Y, ASP60Y, QPIO103Y, QLIO103Y
CDVA
Photopic monocular best corrected distance visual acuity (CDVA), 400cm
Time frame: 3 months after implantation
Defocus curve
Photopic monocular defocus curve, -4.0 D \~ +2.0 D
Time frame: 3 months after implantation
UDVA
Photopic monocular uncorrected distance visual acuity (UDVA), 400cm
Time frame: 3 months after implantation
UIVA
Photopic monocular uncorrected intermediate visual acuity (UIVA), 60cm
Time frame: 3 months after implantation
CIVA
Photopic monocular corrected intermediate visual acuity (CIVA), 60cm
Time frame: 3 months after implantation
IOL glistening
IOL glistening observation
Time frame: 3 months after implantation
PCO
Posterior Capsular Opacification observation
Time frame: 3 months after implantation
Satisfaction questionnaire
Satisfaction questionnaire
Time frame: 3 months after implantation
AE
Signs of inflammation and AEs
Time frame: 3 months after implantation
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Aug 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
ICARES Medicus, Inc.